30 closest matches · ranked by relevance
Asthma
Primary: Baseline-adjusted Area Under the Serial FEV1-time Curve Calculated From Time Zero to 12 Hours (AUC0-12h) on Day 1 of Treatment — 4.03; 3.96 liters x hours
Primary Open Angle Glaucoma · Ocular Hypertension
Primary: Mean Difference in Intraocular Pressure of Both Eyes Between the Two Treatment Groups — 24.92; 25.06; 24.87; 25.12 mmHg
Healthy Volunteers
Primary: Area Under the Concentration (AUC 72) — 37434.51; 33716.80 pg.h/mL
Tinea Pedis
Primary: Proportion of Patients in Each Active Treatment Group Who Are Considered a Therapeutic Cure — 96; 81 Participants
Pain
Primary: Area Under the Curve From Time Zero to Last Sampling Time [AUC(0-t)] — 15.212; 14.698 hours*microgram/millilitre (h*μg/mL)
Bioequivalence
Primary: Concentration Maximum (Cmax) — 0.9092; 0.8711 ng/ml
Obstructive Sleep Apnea
Primary: Apnea/Hypopnea Index — 2.9; 3.2 events/h
Healthy
Primary: Maximum Serum Concentration in Pre Dose Corrected Data (Cmax[aj]) of Levothyroxine (T4) — 67.24; 66.44 nanogram per milliliter (ng/mL)
Bioequivalence
Primary: Concentration Maximum (Cmax) — 1.326; 1.293 ng/ml
Type 2 Diabetes Mellitus
Primary: Saxagliptin Maximum Observed Concentrations (Cmax) — 26.2; 25.5 ng/mL — p=0.4950
Healthy
Primary: Area Under the Concentration Time Curve for Tenofovir, Emtricitabine and Efavirenz — 58.7; 56.7; 10.9; 10.8 mg*hr/mL — p=<0.05
Attention Deficit Hyperactivity Disorder
Primary: Maximum Observed Plasma Concentration (Cmax) — 456; 483 nanogram per millileter (ng/mL)
Healthy
Primary: Area Under the Lamotrigine Concentration vs. Time Curve From Sample Time Point 0 Hour to Sample Time Point 144 Hour. — 119966.6; 121969.5 h*ng/mL
Healthy
Primary: Cmax — 812.477; 945.456 pg/mL — p=0.0328
Healthy
Primary: Area Under the Concentration-time Curve of Nerandomilast in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) — 2275.77; 2166.70…
Healthy
Primary: Area Under the Concentration-time Curve of Nerandomilast in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) — 1270.92; 1320.24…
Healthy
Primary: Part A: Area Under the Concentration-time Curve of Alteplase in Plasma Over the Time Interval From 0 up to the Last Quantifiable Data Point (AUC0-tz)
Epilepsy
Primary: Cmax - Maximum Plasma Concentration — 6461; 13183; 6547; 12988 ng/ml
Chemotherapy-Induced Nausea and Vomiting
Primary: Plasma Area Under The Concentration Versus Time Curve (AUC(0-infinity)) For Ondansetron — 257.8; 262.6 ng*hr/mL
Healthy Adult Subjects
Primary: Area Under the Plasma Concentration Versus Time Curve From Time Zero up to the Last Quantifiable Concentration Time-point (AUC0-t) of Unchanged Edaravone After Oral and…
Epilepsy
Primary: AUC — 101346; 101393 ng*hr/ml
Healthy
Primary: AUC (0-tz) (Area Under the Concentration-time Curve of Metformin in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point) — 6260; 6360 ng*h/mL…
Bronchial Asthma
Primary: Change in FEV1 From Pre Dose to End of Treatment — 0.23; 0.22; 0.09 Litres
HIV/AIDS
Primary: Area Under the Concentration-Time Curve(AUC) — 3.6; 3.4; 85.8; 79.2 hour*milligram/liter
Healthy
Primary: Baseline Corrected Maximum Observed Plasma Concentration (Cmax[Adj]) of Levothyroxine Sodium — 67.258; 60.552 Nanogram per milliliter (ng/mL)
Atrophic Vaginitis
Primary: Number of Participants Identified as a Responder After Completing Study Treatment in the Generic Estradiol Vaginal Cream and Estrace Vaginal Cream Groups — 49; 44…
Hereditary Tyrosinemia, Type I
Primary: Maximum Observed Plasma Concentration (Cmax) — 1277.77; 1272.34; 1339.79 ng/mL
Healthy Volunteers
Primary: Area Under the Curve From Time Zero to Last Quantifiable Concentration (AUClast) — 85020; 90030; 16220; 16120 (nanogram*hour) per milliliter (ng*h/mL)
Healthy
Primary: Area Under the Concentration-time Curve of the Telmisartan in Plasma Over the Time Interval From 0 to the Time of the Last Quantifiable Data Point (AUC0-tz) — 2850; 2790…
Healthy
Primary: Letrozole : AUC0-tz — 2074.71; 2094.63 ng•hr/mL